Human CRY1 (Cryptochrome I) knockout HeLa cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
- WB
Lab
Western blot - Human CRY1 (Cryptochrome I) knockout HeLa cell lysate (AB258382)
Lane 1 : Wild-type HeLa cell lysate 20 ug
Lane 2 : CRY1 knockout HeLa cell lysate 20 ug
Lane 3 : HCT116 cell lysate 20 ug
Lane 4 : Caco-2 cell lysate 20 ug
Lanes 1 - 4 : Merged signal (red and green). Green - ab245564 observed at 66 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab245564 was shown to react with Cryptochrome I/CRY1 in wild-type HeLa cells in Western blot with loss of signal observed in CRY1 knockout cell line ab265791 (CRY1 knockout cell lysate ab258382). Wild-type HeLa and CRY1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab245564 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4 °C at a 1 in 2000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-Cryptochrome I/CRY1 antibody (<a href='/en-us/products/primary-antibodies/cryptochrome-i-cry1-antibody-ab245564'>ab245564</a>) at 1/2000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
CRY1 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human CRY1 (Cryptochrome I) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-cry1-cryptochrome-i-knockout-hela-cell-line-ab265791'>ab265791</a>)
Lane 3:
HCT116 cell lysate at 20 µg
Lane 4:
Caco-2 cell lysate at 20 µg
Predicted band size: 66 kDa
Observed band size: 66 kDa
false
- Sanger seq
Unknown
Sanger Sequencing - Human CRY1 (Cryptochrome I) knockout HeLa cell lysate (AB258382)
Homozygous : 13 bp deletion in exon1
Reactivity data
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com